Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2024 Earnings Call Transcript February 27, 2025
Pacira BioSciences, Inc. beats earnings expectations. Reported EPS is $0.91, expectations were $0.78.
Operator: Good day, and thank you for standing by. Welcome to the Pacira BioSciences Fourth Quarter 2024 Conference Call. [Operator Instructions]. Please note that today’s conference is being recorded. I would now like to turn the call over to Susan Mesco, Head of Investor Relations. Please go...
